Accepted for Publication: September 28, 2022.
Published: November 11, 2022. doi:10.1001/jamanetworkopen.2022.41622
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Son MBF et al. JAMA Network Open.
Corresponding Author: Mary Beth F. Son, MD, Division of Immunology, Boston Children’s Hospital, 300 Longwood Ave, Boston, MA 02115 (email@example.com).
Author Contributions: Dr Son and Ms Berbert had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Son, Canny, Muscal, Prahalad, Zambrano, Randolph.
Acquisition, analysis, or interpretation of data: Berbert, Young, Dallas, Newhams, Chen, Ardoin, Basiaga, Canny, Crandall, Dhakal, Dhanrajani, Sagcal-Gironella, Hobbs, Huie, James, Jones, Kim, Lionetti, Mannion, Muscal, Prahalad, Schulert, Sexson Tejtel, Villacis-Nunez, Wu, Campbell, Patel, Randolph.
Drafting of the manuscript: Son, Berbert, Young, Jones, Prahalad, Schulert.
Critical revision of the manuscript for important intellectual content: Son, Berbert, Young, Dallas, Newhams, Chen, Ardoin, Basiaga, Canny, Crandall, Dhakal, Dhanrajani, Sagcal-Gironella, Hobbs, Huie, James, Kim, Lionetti, Mannion, Muscal, Prahalad, Schulert, Sexson Tejtel, Villacis-Nunez, Wu, Zambrano, Campbell, Patel, Randolph.
Statistical analysis: Berbert, Young, Chen, Ardoin.
Obtained funding: Zambrano, Patel, Randolph.
Administrative, technical, or material support: Son, Dallas, Newhams, Ardoin, Basiaga, Dhakal, Hobbs, Huie, Jones, Kim, Mannion, Schulert, Villacis-Nunez, Zambrano, Campbell, Randolph.
Supervision: Canny, Hobbs, Mannion, Zambrano, Campbell, Patel, Randolph.
Conflict of Interest Disclosures: Dr Son reported receiving grants from the Centers for Disease Control and Prevention (CDC), salary support from the Childhood Arthritis & Rheumatology Research Alliance (CARRA), and royalties from UpToDate during the conduct of the study. Dr Basiaga reported receiving grants from CARRA and the Sjögren’s Foundation outside the submitted work. Dr Canny reported receiving grants from Overcoming COVID-19 during the conduct of the study and receiving grants from the National Institutes of Health (NIH), CARRA/Arthritis Foundation, and the Arthritis National Research Foundation outside the submitted work. Dr Hobbs reported receiving personal fees from DYNAMED.com as a clinical database reviewer, and speaker fees from Biofire/Biomerieux (2021-2022) outside the submitted work. Dr Mannion reported receiving grants from the Rheumatology Research Foundation during the conduct of the study. Dr Muscal reported being a paid member of the Swedish Orphan Biovitrum advisory board outside the submitted work. Dr Prahalad reported receiving personal fees for serving on a committee from Novartis Pharmaceuticals outside the submitted work. Dr Schulert reported receiving personal fees from Swedish Orphan Biovitrum and Novartis outside the submitted work. Dr Sexson Tejtel reported receiving grants from the NIH outside the submitted work. Dr Randolph reported receiving grants from the NIH to Boston Children's Hospital, royalties from UpToDate, and nonfinancial support from Illumina Inc for reagents outside the submitted work. No other disclosures were reported.
Funding/Support: This study was funded by the CDC under contract 75D30120C07725 to Boston Children’s Hospital.
Role of the Funder/Sponsor: The CDC technical staff were coinvestigators involved in the design and conduct of the study; interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The Overcoming COVID-19 Investigators are listed in Supplement 2.
Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the CDC.
LR , Rose
EB , Horwitz
et al; Overcoming COVID-19 Investigators; CDC COVID-19 Response Team. Multisystem Inflammatory syndrome in US children and adolescents. N Engl J Med
. 2020;383(4):334-346. doi:10.1056/NEJMoa2021680
BW , Rowley
AH , Newburger
et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation
. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484
J , Poirault
C , Corsia
et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ
. 2020;369:m2094. doi:10.1136/bmj.m2094
PY , Day-Lewis
M , Henderson
et al. Distinct clinical and immunological features of SARS-CoV-2–induced multisystem inflammatory syndrome in children. J Clin Invest
. 2020;130(11):5942-5950. doi:10.1172/JCI141113
DJ , Sartori
LF , Chiotos
et al. Distinguishing multisystem inflammatory syndrome in children from Kawasaki disease and benign inflammatory illnesses in the SARS-CoV-2 pandemic. Pediatr Emerg Care
. 2020;36(11):554-558. doi:10.1097/PEC.0000000000002248
B , Gorelik
M , Boneparth
et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children’s hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr Crit Care Med
. 2021;22(3):e178-e191. doi:10.1097/PCC.0000000000002598
LA , Canna
SW , Friedman
et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 3. Arthritis Rheumatol
. 2022;74(4):e1-e20. doi:10.1002/art.42062
R , Allin
B , Jones
et al; PIMS-TS National Consensus Management Study Group. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health
. 2021;5(2):133-141. doi:10.1016/S2352-4642(20)30304-7
T , Saji
T , Otani
et al; RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet
. 2012;379(9826):1613-1620. doi:10.1016/S0140-6736(11)61930-2
N , Toubiana
J , Antona
et al; French Covid-19 Paediatric Inflammation Consortium. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA
. 2021;325(9):855-864. doi:10.1001/jama.2021.0694
T , Kobayashi
T , Morikawa
et al. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. J Pediatr
. 2013;163(2):521-526. doi:10.1016/j.jpeds.2013.01.022
E , Altman
DG , Egger
M , Pocock
SJ , Gøtzsche
PC , Vandenbroucke
JP ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol
. 2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008
L , Motta
F , De Santis
M , Ansari
AA , Gershwin
ME , Selmi
C . The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19—a systematic review of the literature. J Autoimmun
. 2021;117:102592. doi:10.1016/j.jaut.2020.102592
CE , Koyama
AK , Alvarez
et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years—United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep
. 2022;71(2):59-65. doi:10.15585/mmwr.mm7102e2
DT , Trachtenberg
FL , Pearson
et al; MUSIC Study Investigators (Supplement 1). The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. Am Heart J
. 2022;243:43-53. doi:10.1016/j.ahj.2021.08.003PubMedGoogle ScholarCrossref
LR , Tenforde
MW , Friedman
et al; Overcoming COVID-19 Investigators. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA
. 2021;325(11):1074-1087. doi:10.1001/jama.2021.2091
S , Nigrovic
PA , Feldman
et al. The Childhood Arthritis and Rheumatology Research Alliance Consensus treatment plans: toward comparative effectiveness in the pediatric rheumatic diseases. Arthritis Rheumatol
. 2018;70(5):669-678. doi:10.1002/art.40395
J , Kruger
A , Masha
et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 Omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health
. 2022;6(5):294-302. doi:10.1016/S2352-4642(22)00027-X
CV , Bowden
SA , Boktor
SW . Pediatric type 2 diabetes mellitus. StatPearls Publishing; 2022.
EM , Koumans
EH , Chow
et al; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med
. 2020;383(4):347-358. doi:10.1056/NEJMoa2021756
E , Bamford
A , Kenny
et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA
. 2020;324(3):259-269. doi:10.1001/jama.2020.10369